Provider 1952876203
Total Paid
$12.4M
$12,397,592
Total Claims
302K
Beneficiaries
163K
1.9 claims/patient
Avg Cost/Claim
$41
Monthly Spending Trend
Yearly Spending
Procedure Breakdown
Cost per claim compared to national benchmarks
This provider bills for 30 distinct procedure codes. The top code (G0480 (Drug test, definitive, 1-7 drug classes)) accounts for 25% of total spending.
$3.1M
51K claims
$62.06
$37.56
Drug test, definitive, 1-7 drug classes
$3.1M
51K claims · 25.3%
$2.9M
54K claims
$54.32
$60.05
COVID-19 test, nucleic acid detection, CDC lab only
$2.9M
54K claims · 23.8%
$2.7M
75K claims
$36.14
$35.43
Drug test, presumptive, by chemistry analyzers
$2.7M
75K claims · 21.7%
$1.4M
13K claims
$110.28
$90.89
Drug test, definitive, 22+ drug classes
$1.4M
13K claims · 11.1%
$913K
54K claims
$16.97
$15.76
Infectious disease detection, COVID-19, antigen
$913K
54K claims · 7.4%
$872K
5,679 claims
$153.46
$75.26
Drug test, definitive, 15-21 drug classes
$872K
5,679 claims · 7.0%
$366K
48K claims
$7.56
$17.15
Specimen collection for COVID-19 testing
$366K
48K claims · 3.0%
$90K
1,692 claims
$53.26
$64.72
Drug test, definitive, 8-14 drug classes
$90K
1,692 claims · 0.7%
$17
35 claims · 0.0%
$16
31 claims · 0.0%
$15
34 claims · 0.0%
$15
34 claims
$0.45
$5.78
Benzodiazepine drug assay by definitive method
$15
34 claims · 0.0%
$15
35 claims · 0.0%
$15
35 claims · 0.0%
$15
34 claims · 0.0%
$15
35 claims · 0.0%
$15
35 claims · 0.0%
$15
34 claims · 0.0%
$15
33 claims · 0.0%
$15
33 claims · 0.0%
$15
35 claims · 0.0%
$15
35 claims · 0.0%
$15
33 claims · 0.0%
$15
34 claims · 0.0%
$15
35 claims · 0.0%
$15
34 claims · 0.0%
$15
35 claims · 0.0%
$14
35 claims · 0.0%
$14
35 claims
$0.40
$5.26
Benzodiazepine drug level, definitive method, each
$14
35 claims · 0.0%
$14
34 claims · 0.0%